David Bodmer
12Patents
8h-index
24Co-inventors
72Inventor score
Filing activity: Jan 18, 1991 → Mar 16, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5639480A | Sustained release formulations of water soluble peptides | Human Necessities | 179 | Expired |
| US5538739A | Sustained release formulations of water soluble peptides | Chemistry; Metallurgy | 119 | Expired |
| US6262127A | Polymeric matrices and their uses in pharmaceutical compositions | Emerging Cross-Sectional Technologies | 33 | Expired |
| US5876761A | Sustained release formulations of water soluble peptides | Human Necessities | 28 | Expired |
| US5688530A | Sustained release formulations of water soluble peptides | Chemistry; Metallurgy | 27 | Expired |
| US8822637B2 | Somatostatin analogues | Emerging Cross-Sectional Technologies | 14 | Active |
| US6083521A | Polymeric matrices and their uses in pharmaceutical compositions | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7473761B2 | Somatostatin analogues | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6623753B1 | Allylamine-containing liposomes | Human Necessities | 5 | Expired |
| US6204308A | Organic compounds | Human Necessities | 1 | Expired |
| US9035021B2 | Somatostatin analogues | Emerging Cross-Sectional Technologies | 0 | Active |
| US7939625B2 | Somatostatin analogues | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.